Now published: We used FEP to classify integrin-binding ligands as "opening" or "closing" which can help design safe small-molecule inhibitors as potential new therapeutics.
doi.org/10.1021/jacs...
@martinvoegele.bsky.social
@martinvoegele.bsky.socialNow published: We used FEP to classify integrin-binding ligands as "opening" or "closing" which can help design safe small-molecule inhibitors as potential new therapeutics.
doi.org/10.1021/jacs...
@markfortner.bsky.socialGive us 10 minutes and we'll show you how Digital Transformation with AI and Automation can change your drug discovery operations.
@aspenbio.bsky.socialGive us 10 minutes and we'll show you how Digital Transformation with AI and Automation can change your drug discovery operations.
@piellab.bsky.socialWe found the uncultivated bacterium producing the anticancer drug candidate peloruside A and hiding in an NZ sponge!
It uses a new biochemical trick in complex polyketide biosynthesis.
Congrats Amy, our Victoria University NZ collaborators, and the whole team!
#DrugDiscovery
@medinadiscovery.bsky.socialGC ADDA H3D Foundation #RAFIKI #EUOPENSCREEN #DrugDiscovery #NaturalProducts #GlobalHealth #AfricaScience #ResearchTraining #EarlyCareerResearchers
@annualreviews.bsky.socialTomorrow's breakthrough treatments may come from drugs we use now. How is AI using genomics and multiomics data to support drug discovery?
🔗 Freely available thanks to S2O: arevie.ws/45wyEca
✨New to our AI, Machine Learning, and Society collection
@fiosgenomics.bsky.socialNot sure about the steps involved in the Preclinical Phase of drug development? This video explains what happens at each stage, from #drugdiscovery to #toxicology! ▶️
https://youtu.be/5Z5jh02KxkY?feature=shared
#preclinicalresearch #drugdevelopment #bioinformatics
@prof-clark.bsky.socialAI may transform AMD drug discovery, but algorithms generate hypotheses, not biological proof. Validation, generalisability and mechanism remain the real tests. #AI #AMD #DrugDiscovery buff.ly/9wRiLTr
@markfortner.bsky.socialGot 8 minutes? Let us show you how the Pipeline Drug Discovery platform can transform your research operations, reduce risk & costs, and improve collaboration.
Contact us at [email protected]
#DrugDiscovery #AI #Assays #PM #Chem #ProteinProduction #TargetManagement
@aspenbio.bsky.socialGot 8 minutes? Let us show you how the Pipeline Drug Discovery platform can transform your research operations, reduce risk & costs, and improve collaboration.
Contact us at [email protected]
#DrugDiscovery #AI #Assays #PM #Chem #ProteinProduction #TargetManagement
@gmj-georgia.bsky.socialEli Lilly has invested in Absci, an AI biotech startup developing novel hair loss treatments that could reshape dermatological care. The… #Artificialintelligence #Drugdiscovery #EliLilly #Hairlosstreatment #Pharmaceuticalinnovation #Artificialintelligence #Drugdiscovery #EliLilly #Hairlosstreat…
@aspenbio.bsky.socialAt Aspen Biosciences, we provide drug discovery companies with the tools they need to create new medicines. To learn more, visit us at bit.ly/3CtV2VC or contact us at [email protected]
@markfortner.bsky.socialAt Aspen Biosciences, we provide drug discovery companies with the tools they need to create new medicines. To learn more, visit us at bit.ly/3CtV2VC or contact us at [email protected]
@protifi.bsky.socialJoin us at Booth 14 at the CASSS Mass Spec Symposium next week to discover how ProtiFi™ can reduce your method development processes with a standardized MAM workflow in drug discovery and QC environments. See you there!
#ProtiFi™ #MAM #DrugDiscovery #Biopharma #Biotech #Innovation
@imerit.bsky.socialAI is advancing drug discovery, but Phase II success remains 40% vs. 80–90% in Phase I.
The gap? Thin translational data and limited expert scientific reasoning. See how iMerit Scholars helps bridge the gap between prediction and outcomes:
imerit.ai/resources/bl...
@ertrunnell.bsky.social💡 @fda.gov should establish a similar pathway.
The U.S. is a global leader in #biotech.
Making data from these methods easier to share could help connect discoveries from academic labs with medicine developers and strengthen the scientific foundation of #drugdiscovery.
@kuglerelisabeth.bsky.socialWe also looked ahead to the future of AI, the changing needs of scientific professionals, and what the next 20 years could bring.
🎥 Watch our full interview: youtu.be/xIbgXVyGrNw
Register for Drug Discovery 2026: elrig.org/portfolio/dr...
@newsmedical.bsky.social🦂 Could scorpion venom hold the key to new liver disease therapies? See how its peptides are being explored for anti-inflammatory and antiviral effects. www.news-medical.net/news/2026090... #ScorpionVenom #LiverDisease #Biotech #DrugDiscovery
@aging-us.bsky.socialAging is pleased to announce that we are a media partner of the 13th Aging Research & Drug Discovery Meeting (ARDD), taking place October 1–3 at Harvard University in Boston, MA.
🔗 Learn more:
https://bit.ly/3UfNcue
@markfortner.bsky.socialEarly Data Indicates an AI-generated Drug Could Slow Aging | #AI #DrugDiscovery #aging #InsilicoMedicine